However, PEDF-silenced OM-MSCs exhibited a reduced neuroprotective effect on the activation of the PI3k/Akt/mTOR pathway, probably indicating the direct regulation impact of OM-MSC-derived PEDF on this pathway. The gene discussed is MTOR; the disease is ocular melanoma.